HIGH-DOSE CHEMOTHERAPY (HDC) AND PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) SUPPORT PLUS G-CSF ON DAY 6 POSTTRANSPLANT IN RESPONDING MESTASTATIC BREAST-CANCER (MBC)
E. Delbarco et al., HIGH-DOSE CHEMOTHERAPY (HDC) AND PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) SUPPORT PLUS G-CSF ON DAY 6 POSTTRANSPLANT IN RESPONDING MESTASTATIC BREAST-CANCER (MBC), Annals of oncology, 9, 1998, pp. 109-109